Patient satisfaction may be increasingly important in healthcare, but the industry hasn't made the appropriate changes yet, 2 employees from Prime Therapeutics said in back-to-back sessions at the 64th Annual Roy A. Bowers Pharmaceutical Conference.
Patient satisfaction may be increasingly important in healthcare, but the industry hasn’t made the appropriate changes yet, 2 employees from Prime Therapeutics said in back-to-back sessions at the 64th Annual Roy A. Bowers Pharmaceutical Conference held by Rutgers University.
Ingrid Lindberg, chief customer experience officer at Prime, explained that for many people, their first experience with the company is when they hear someone else complaining that they didn’t receive their medication or that the process was too difficult.
“The consumer is king,” Ms Lindberg said. “And if you think that the consumer is not going to be king, then you are outdated.”
Her colleague, Cory Busse, senior director of clinical product management, discussed that one reason patients are unhappy is because of the lack of interoperability among health information systems. In recent years, so many electronic health record (EHR) vendors have popped up that they, intentionally or not, have created systems that don’t speak to one another.
“[At Prime] we don’t talk about data in terms of big data and small data; we talk about data in terms of dumb data and smart data,” he said. “We recognize that our role … is to take dumb data, make it smarter, and then put it back into the hands of people who can do something about it, which is mainly doctors and pharmacists, but increasingly members, who have the greatest stake in their overall healthcare to begin with.”
He explained the dichotomy that exists between the doctor and the pharmacist. While the doctor has a comprehensive view of the patient, he or she has no idea what the drug will cost or what is on the formulary. In contrast, the pharmacist knows the formulary and the copay information, but is not privy to a holistic view of the patient’s medical data.
Ideally, Mr Busse said, providers would be able to see formulary and copayment information at the plan level, specific to the member. Instead, they only see that the patient is potentially covered for a drug, and the worst case scenario for how much it could cost a patient. He used Abilify as an example and described that in the EHR, physicians would see that the patient could be responsible for up to $10 billion.
“This is the dirty little secret of our industry: the data are not accurate,” Mr Busse said.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More